Annual Accounts Payable
$16.02 M
+$7.27 M+83.05%
31 December 2023
Summary:
Pharming Group NV annual accounts payable is currently $16.02 million, with the most recent change of +$7.27 million (+83.05%) on 31 December 2023. During the last 3 years, it has risen by +$2.55 million (+18.94%). PHAR annual accounts payable is now -60.58% below its all-time high of $40.65 million, reached on 31 December 2019.PHAR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$72.64 M
-$329.00 K-0.45%
30 September 2024
Summary:
Pharming Group NV quarterly accounts payable is currently $72.64 million, with the most recent change of -$329.00 thousand (-0.45%) on 30 September 2024. Over the past year, it has increased by +$10.10 million (+16.15%). PHAR quarterly accounts payable is now -0.45% below its all-time high of $72.97 million, reached on 30 June 2024.PHAR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +83.0% | +16.1% |
3 y3 years | +18.9% | +72.3% |
5 y5 years | +110.9% | +93.8% |
PHAR Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +110.8% | -0.5% | +855.9% |
5 y | 5 years | -60.6% | +110.9% | -0.5% | +855.9% |
alltime | all time | -60.6% | +1342.4% | -0.5% | +6439.3% |
Pharming Group NV Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $72.64 M(-0.5%) |
June 2024 | - | $72.97 M(+6.5%) |
Mar 2024 | - | $68.52 M(+327.6%) |
Dec 2023 | $16.02 M(+83.0%) | $16.02 M(-74.4%) |
Sept 2023 | - | $62.54 M(+5.5%) |
June 2023 | - | $59.30 M(+11.4%) |
Mar 2023 | - | $53.25 M(+508.4%) |
Dec 2022 | $8.75 M(+15.2%) | $8.75 M(-79.5%) |
Sept 2022 | - | $42.74 M(-5.2%) |
June 2022 | - | $45.07 M(+10.4%) |
Mar 2022 | - | $40.83 M(+437.3%) |
Dec 2021 | $7.60 M(-43.6%) | $7.60 M(-82.0%) |
Sept 2021 | - | $42.15 M(-2.3%) |
June 2021 | - | $43.14 M(-1.1%) |
Mar 2021 | - | $43.60 M(+223.7%) |
Dec 2020 | $13.47 M(-66.9%) | $13.47 M(-66.9%) |
Sept 2020 | - | $40.65 M(-14.3%) |
June 2020 | - | $47.41 M(+0.9%) |
Mar 2020 | - | $46.99 M(+15.6%) |
Dec 2019 | $40.65 M(+435.0%) | $40.65 M(+8.4%) |
Sept 2019 | - | $37.49 M(+12.0%) |
June 2019 | - | $33.47 M(+14.2%) |
Mar 2019 | - | $29.31 M(+285.7%) |
Dec 2018 | $7.60 M(-32.8%) | $7.60 M(-79.0%) |
Sept 2018 | - | $36.22 M(+17.1%) |
June 2018 | - | $30.93 M(-13.4%) |
Mar 2018 | - | $35.71 M(+215.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $11.31 M(+90.3%) | $11.31 M(-43.4%) |
Sept 2017 | - | $20.00 M(+16.5%) |
June 2017 | - | $17.16 M(-4.9%) |
Mar 2017 | - | $18.04 M(+203.5%) |
Dec 2016 | $5.94 M(+435.1%) | $5.94 M(-45.5%) |
Sept 2016 | - | $10.90 M(-3.9%) |
June 2016 | - | $11.34 M(+7.8%) |
Mar 2016 | - | $10.52 M(+846.6%) |
Dec 2015 | $1.11 M(-69.0%) | $1.11 M(-87.6%) |
Sept 2015 | - | $8.98 M(-0.9%) |
June 2015 | - | $9.06 M(-2.6%) |
Mar 2015 | - | $9.30 M(+159.9%) |
Dec 2014 | $3.58 M(-35.6%) | $3.58 M(-51.9%) |
Sept 2014 | - | $7.45 M(+66.3%) |
June 2014 | - | $4.48 M(-54.3%) |
Mar 2014 | - | $9.79 M(+76.1%) |
Dec 2013 | $5.56 M(+273.4%) | $5.56 M(+16.7%) |
Sept 2013 | - | $4.76 M(+34.0%) |
June 2013 | - | $3.56 M(-38.2%) |
Mar 2013 | - | $5.75 M(+286.4%) |
Dec 2012 | $1.49 M(-43.9%) | $1.49 M(-80.3%) |
Sept 2012 | - | $7.56 M(+184.8%) |
Dec 2011 | $2.65 M(-76.7%) | $2.65 M(-72.0%) |
June 2010 | - | $9.47 M(-16.0%) |
Mar 2010 | - | $11.28 M |
Dec 2007 | $11.42 M(+13.6%) | - |
Dec 2006 | $10.05 M | - |
FAQ
- What is Pharming Group NV annual accounts payable?
- What is the all time high annual accounts payable for Pharming Group NV?
- What is Pharming Group NV annual accounts payable year-on-year change?
- What is Pharming Group NV quarterly accounts payable?
- What is the all time high quarterly accounts payable for Pharming Group NV?
- What is Pharming Group NV quarterly accounts payable year-on-year change?
What is Pharming Group NV annual accounts payable?
The current annual accounts payable of PHAR is $16.02 M
What is the all time high annual accounts payable for Pharming Group NV?
Pharming Group NV all-time high annual accounts payable is $40.65 M
What is Pharming Group NV annual accounts payable year-on-year change?
Over the past year, PHAR annual accounts payable has changed by +$7.27 M (+83.05%)
What is Pharming Group NV quarterly accounts payable?
The current quarterly accounts payable of PHAR is $72.64 M
What is the all time high quarterly accounts payable for Pharming Group NV?
Pharming Group NV all-time high quarterly accounts payable is $72.97 M
What is Pharming Group NV quarterly accounts payable year-on-year change?
Over the past year, PHAR quarterly accounts payable has changed by +$10.10 M (+16.15%)